DLX6 and type 2 diabetes mellitus: Specifically, a significant increase in DLX6-AS1 expression in the DR group relative to the T2DM group was only observed in patients without a history of fatty liver (1.37 ± 0.67 vs. 0.91 ± 0.27, P = 0.019).